HIV-HBV
Coinfection Top News Articles |
|
|
| SMART
Study Shows Antiretroviral Treatment Interruption Is Particularly Risky for Patients
with HIV-HBV or HIV-HCV Coinfection - 12/05/2008 |
| Baseline
CD4 Cell Count Predicts HBV DNA Decline in
HIV Negative and HIV Positive Patients Treated
with Adefovir (Hepsera) - 12/05/2008 |
| Management
of HIV Positive Patients with Chronic Hepatitis B
Who Are Not Eligible for Antiretroviral Therapy - 11/25/2008 |
| Tenofovir
(Viread) for Patients with HIV-HBV Coinfection - 11/21/2008 |
| HAART
Improves Hepatitis B Vaccine Response Regardless of CD4 Count - 11/07/2008 |
 | Liver
Enzyme Elevations in HIV Positive Individuals with Occult
Hepatitis B Virus Infection - 10/17/08
|
 | Thai
Study Confirms Efficacy of Tenofovir (Viread)
Regimens for HIV-HBV Coinfected Patients - 10/14/08
|
| Laboratory
Study Provides Details on Entecavir (Baraclude)
Activity against Various Types of HIV -
8/29/08 |
| HIV
Positive Individuals Are at Higher Risk of Occult
Hepatitis B Virus Infection, but Occult Hepatitis C Virus Is Rare
- 8/22/08 |
| Predictors
of Hepatitis B Surface Antigen Loss in HIV-HBV Coinfected
Individuals -
8/08/08 |
| Updated
Recommendations for Management of HIV Positive Patients
with Chronic Hepatitis B Virus Coinfection -
7/15/2008 |
| Multicenter
Evaluation Sheds Further Light on Anti-HIV Activity of Entecavir
(Baraclude) -
6/20/08 |
| Influence
of Occult Hepatitis B Virus on Liver Disease Progression and Response
to Interferon-based Therapy in HIV-HCV Coinfected Patients
- 6/10/08 |
| FDA
Proposes New Rule to Provide Updated Information on Use of Prescription Drugs
and Biological Products during Pregnancy and Breast-feeding -
5/30/08 |
 | Risk
of Using Entecavir (Baraclude) without Concomitant Antiretroviral Therapy in HIV-HBV
Coinfected Patients -
5/15/08 |
 | Hepatitis
B Coinfection Does
Not Interfere with Response to Antiretroviral Therapy -
4/15/08 |
 | Another
Report of Drug-resistant HIV in a Patient
Treated with Entecavir (Baraclude) for Hepatitis
B -
4/11/08 |
 | Hepatitis
Flares in HIV-HBV
Coinfected Patients
Starting HAART May Be Due to Immune Restoration -
3/04/08 |
 | HIV
Coinfection Contributes
to Mortality Related to
Chronic Hepatitis B and
C in France
-
2/29/08 |
 | Hepatitis
B Coinfection Does
Not Impact HIV Suppression or CD4 Cell Recovery on HAART -
2/26/08 |
| Two
Studies Look at Anti-HIV Activity of Entecavir (Baraclude) -
2/12/08 |
| Effect
of HAART and Hepatitis B Vaccination on Epidemiology of HIV-HBV
Coinfection - 2/05/08 |
| HIV
Entry into Hepatic Stellate Cells Promotes Liver Fibrosis Progression - 2/05/08 |
| HAART
Containing Tenofovir (Viread) plus Emtricitabine (Emtriva) Is Effective for HIV-HBV
Coinfected Patients, but
Treatment Should Not Be Interrupted - 1/11/08 |
| Antiretroviral
Therapy Improves Poor Prognosis among HIV-HCV and
HIV-HBV Coinfected Patients
with Liver Cirrhosis - 12/14/07 |
| Studies
Look at Triple or Quadruple Infection with
HBV,
HCV,
and HDV in HIV Positive Individuals -
12/11/07 |
| Liver
Enzyme Elevation and Immune Reconstitution in HIV Patients
with and without Hepatitis B or C Coinfection
- 12/07/07 |
| HIV-HBV
Coinfected Liver
Transplant Recipients Have Outcomes Similar to Those of HIV Negative Patient |
| Hepatitis
B Serological Markers May Change over Time in HIV-HBV
Coinfected
Individuals on Antiretroviral Therapy - 10/19/07 |
| Mutations
Associated with Lamivudine (3TC; Epivir) Resistance in Previously Untreated
Hepatitis B Patients with and without HIV -
10/12/07 |
| Good
Response to Hepatitis B Treatment Is Associated Sustained Response to Antiretroviral
Therapy in
HIV-HBV Coinfected Patients
- 9/25/07 |
| Bristol-Myers
Squibb Warns Providers about Anti-HIV Activity of Entecavir (Baraclude) in
HIV-HBV Coinfected Patients - 8/21/07 |
| Presence
of Mixed Hepatitis B Genotypes Occurs More Frequently in HIV-HBV
Coinfected Patients - 8/17/07 |
| Liver
Disease and Survival Outcomes in HIV-HBV Coinfected Individuals
- 8/17/07 |
| Safety
of Atazanavir (Reyataz) in HIV-HBV and HIV-HCV
Coinfected Patients with Pre-existing Liver Disease
- 8/10/07 |
| Hepatitis
B Virus and HIV Coinfection: Results of a Survey on Treatment Practices
and Recommendations for Therapy - 8/10/07 |
| HIV
Positive Individuals More Likely to Respond to High-dose HBV
Vaccine - 8/03/07 |
| Complete
HBV Genome Analysis in HIV
Coinfected Individuals Identifies a Novel Core/precore Mutant - 8/03/07 |
| HAART
Regimens Containing Tenofovir (Viread) or Lamivudine (Epivir) in HIV-HBV
Coinfected Patients - 7/31/07 |
| Impact
of Antiretroviral Treatment Interruption among HIV-HCV and HIV-HBV
Coinfected Patients in the SMART Trial - 7/31/07 |
| Liver
Toxicity Among HIV Positive African Patients on HAART is Associated with Tuberculosis
Therapy and
Hepatitis B Coinfection - 7/07/07 |
| Epidemiology,
Diagnosis, and Treatment of Chronic
Hepatitis B in HIV Positive Patients - 7/03/07 |
| Experimental
HBV Drug Clevudine Shows Promise at the XVI International HIV Drug Resistance
Workshop in Barbados
- 6/19/07 |
| When
HIV and Liver Disease Co-exist
- 6/12/07 |
| Hepatitis
Delta Infection May Worsen Disease Progression in HIV-HBV
Coinfected Individuals
- 5/25/07 |
| Revised
Treatment Guidelines for Use of Entecavir in HIV-HBV
Coinfected Patients -
5/11/07 |
| HAART
Regimens Containing Tenofovir Plus Lamivudine or Emtricitabine Work Best for
HIV-HBV Coinfected Patients -
5/01/07 |
| Role
of HIV
Coinfection in
Mortality Related to Hepatitis
B
or C - 4/24/07 |
| Do
HIV
Care Providers Appropriately Manage
Hepatitis B in Coinfected Patients? -
4/10/07 |
| HBV
Less Likely than HCV to Cause
Liver Disease Progression and Death in People
with HIV - 4/06/07 |
| Treatment
of Chronic Hepatitis B or C in HIV
Positive Patients with Triple Infection -
4/3/07 |
| Emergence
of Tenofovir-resistant Mutations Is Uncommon in
HIV-HBV Coinfected Patients -
4/3/07 |
| Hepatitis
B Virus Kinetics
and Treatment Response in HIV-HBV
Coinfected Patients -
3/30/07 |
| Long-term
Lamivudine plus Tenofovir Is Safe and Effective in HIV-HBV
Coinfected Patients -
3/27/07 |
| HBV
Vaccination in
HIV Positive People 3/20/07 |
| Outcomes
in HIV-HBV Coinfected Patients Treated with
Drugs Active Against Both Viruses 10/17/06 |
 | Safety
of Atazanavir in Patients with HIV/HCV or HIV/HBV Coinfection
9/12/06 |
|